Shreya Tripathi

From Wikipedia, the free encyclopedia
Shreya Tripathi
Died9 October 2018
NationalityIndian
Occupationhealth activist

Shreya Tripathi (died 9 October 2018) was an Indian health activist.

Tripathi was diagnosed with tuberculosis in 2012.[1] She sought treatment but her strain was found to be extensively drug-resistant tuberculosis, rendering the usual medications ineffective.[1] The Revised National TB Control Program (RNTCP) in India declined to provide her with bedaquiline, a newer drug intended for such cases.[2] With the assistance of Anand Grover, Tripathi filed suit against the RNTCP to force the organization to provide access to the medication.[2] On 20 January 2017, the High Court in Delhi ruled in favour of Tripathi and ordered that she receive the drug.[3] The court further ordered that bedaquiline be made available at 70 Indian treatment centres; it had previously only be obtainable at six.[4] Although her suit was successful, the treatment delay resulted in irreversible scarring to Tripathi's lungs, resulting in her death.[2]

Stephen Lewis highlighted Tripathi's story in a 2017 keynote address.[4] In an article written after Tripathi's death, Lewis and suggested that Tripathi "belongs with Malala and Greta in the pantheon of teenagers whose unswerving principles have brought the powerful to their knees".[3]

References[]

  1. ^ a b Amrit Dhillon (13 January 2017). "Politics and protocol leave Indian teen's life in the balance pending TB drug ruling". The Guardian.
  2. ^ a b c Jennifer Furin (30 March 2019). "TB Killed Shreya Tripathi, But Her Death Could Have Been Avoided". The Wire.
  3. ^ a b Stephen Lewis and Jennifer Furin (24 March 2019). "India should heed a teenager's historic fight for lifesaving tuberculosis treatment". Stat News.
  4. ^ a b "Keynote by Stephen Lewis delivered at the 21st Annual Conference of The Union - North America Region, Vancouver, Canada, February 24, 2017" (PDF).
Retrieved from ""